NUVALENT INC's ticker is and the CUSIP is 670703107. A total of 92 filers reported holding NUVALENT INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,303 | 0.0% | 17,000 | 0.0% | 0.00% | 0.0% |
| Q1 2024 | $1,303 | +2.1% | 17,000 | 0.0% | 0.00% | -33.3% |
| Q4 2023 | $1,276 | +61.1% | 17,000 | 0.0% | 0.00% | +50.0% |
| Q3 2023 | $792 | -7.6% | 17,000 | -15.0% | 0.00% | 0.0% |
| Q2 2023 | $857 | -32.6% | 20,000 | -60.0% | 0.00% | -33.3% |
| Q1 2023 | $1,271 | +6.3% | 50,000 | +25.0% | 0.00% | 0.0% |
| Q4 2022 | $1,196 | -99.9% | 40,000 | -33.3% | 0.00% | -25.0% |
| Q3 2022 | $1,208,000 | +189.0% | 60,000 | +100.0% | 0.00% | +300.0% |
| Q2 2022 | $418,000 | +56.6% | 30,000 | +114.3% | 0.00% | 0.0% |
| Q4 2021 | $267,000 | – | 14,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 19,991,024 | $1,516,519,081 | 25.23% |
| Bain Capital Life Sciences Investors, LLC | 2,697,267 | $204,614,675 | 22.46% |
| Fairmount Funds Management LLC | 1,924,626 | $146,002,128 | 16.50% |
| Paradigm Biocapital Advisors LP | 4,571,678 | $346,807,493 | 13.27% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 465,710 | $35,328,761 | 8.34% |
| COMMODORE CAPITAL LP | 1,487,756 | $112,861,170 | 7.70% |
| Perceptive Advisors | 2,549,077 | $193,372,981 | 4.66% |
| Boxer Capital, LLC | 1,120,192 | $84,977,765 | 4.48% |
| First Turn Management, LLC | 252,276 | $19,137,657 | 3.11% |
| Ikarian Capital, LLC | 151,601 | $11,500,452 | 2.00% |